Overview
Frans Helmerhorst practices in Leiden, Netherlands. Mr. Helmerhorst is rated as an Experienced expert by MediFind in the treatment of Superficial Thrombophlebitis. His top areas of expertise are Factor V Leiden Thrombophilia, Mesenteric Venous Thrombosis, Deep Vein Thrombosis, Intrauterine Device Insertion, and Hormone Replacement Therapy (HRT).
His clinical research consists of co-authoring 46 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Zuideinde, OV, Netherlands
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Deep Vein ThrombosisMr. Helmerhorst isAdvanced. Learn about Deep Vein Thrombosis.
- Factor V Leiden ThrombophiliaMr. Helmerhorst isAdvanced. Learn about Factor V Leiden Thrombophilia.
- Intrauterine Device InsertionMr. Helmerhorst isAdvanced. Learn about Intrauterine Device Insertion.
- Mesenteric Venous ThrombosisMr. Helmerhorst isAdvanced. Learn about Mesenteric Venous Thrombosis.
- Experienced
- Blood ClotsMr. Helmerhorst isExperienced. Learn about Blood Clots.
- Hormone Replacement Therapy (HRT)Mr. Helmerhorst isExperienced. Learn about Hormone Replacement Therapy (HRT).
- InfertilityMr. Helmerhorst isExperienced. Learn about Infertility.
- MenopauseMr. Helmerhorst isExperienced. Learn about Menopause.
- Superficial ThrombophlebitisMr. Helmerhorst isExperienced. Learn about Superficial Thrombophlebitis.